Non-invasive prenatal testing (NIPT) on pregnant women to detect the risk of a fetus having rare genetic abnormalities may often be wrong, according to recent reports. These tests, according to ...

Myriad Genetics, Inc. announced it will present significant research on early prenatal testing at the Society for Maternal-Fetal Medicine Conference. The study, awarded the Dru Carlson Memorial Award, ...

WASHINGTON , Jan. 6, 2026 /PRNewswire/ -- A new study indicates that noninvasive prenatal screening (NIPS) performed using a low-cost form of whole genome sequencing can detect pregnant mothers at ...

Nearly 100 Republican legislators are demanding answers from the Food and Drug Administration (FDA) on the nature and validity of non-invasive prenatal testing (NIPT). Rep. Chip Roy, R-Texas, Sen.

The tests look for genetic abnormalities in a fetus, according to the FDA. Common prenatal tests done to test for genetic abnormalities are the subject of a new warning from the U.S. Food and Drug ...

ProPublica is a nonprofit newsroom that investigates abuses of power. Sign up to receive our biggest stories as soon as they’re published. Expecting parents want to do the right thing. When the doctor ...

A disturbing report from The New York Times on the unreliability of prenatal blood testing for genetic abnormalities should do more than make us wish that the testing companies were better regulated.

A new study indicates that noninvasive prenatal screening (NIPS) performed using a low-cost form of whole genome sequencing can detect the risk in pregnant mothers of transmitting cytomegalovirus (CMV ...